Prediction of early pregnancy maternal thyroid impairment in women affected with unexplained recurrent miscarriage

Human Reproduction

Volumn 26, Issue 6, 2011, Pages 1324-1330

  Dal Lago, Alessandro ^a   Vaquero, Elena ^b   Pasqualetti, Patrizio ^c,d   Lazzarin, Natalia ^b   De Carolis, Caterina ^e   Perricone, Roberto ^b   Moretti, Costanzo ^b,f  

^a Operative Unit of Spontaneous Recurrent Abortion   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

^e SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^f SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

iTSHa; pregnancy; recurrent miscarriage; thyroid; TSH

Indexed keywords

LIOTHYRONINE; PROTIRELIN; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; EARLY PREGNANCY MATERNAL THYROID IMPAIRMENT; EUTHYROIDISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PREDICTION; PREGNANCY DISORDERS OF ENDOCRINE ORIGIN; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPONTANEOUS ABORTION; THYROID FUNCTION;

EID: 79957501070     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der069     Document Type: Article

References (33)

1. Abalovich M, Amino N, Barbour LA, Cobin RH, DeGroot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A. Management of thyroid dysfunction during pregnancy and postpartum: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2007;92:S1-S47. (Pubitemid 47236338)
2. Abramson J, Stagnaro-Green A. Thyroid antibodies and fetal loss: An evolving story. Thyroid 2001;11:57-63. (Pubitemid 32127413)
3. Allan WC, Haddow JE, Palomaki GE,Williams JR, Mitchell ML, Hermos RJ, Faix JD, Klein RZ. Maternal thyroid deficiency and pregnancy complications: Implications for population screening. J Med Screen 2000;7:127-130.
4. American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002;8:457-469.
5. Ashitaka Y, Maruo M, Takeuchi Y, Nakayama H, Mochizuchi M. 3,5,3'-Triiodo-L-thyronine binding sites in nuclei of trophoblastic cells. Endocrinol Jpn 1988;35:197-206. (Pubitemid 19006047)
6. Benhadi N, Wiersinga WN, Reitsma JB, Vrijkotte TGM, Bonsel GJ. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol 2009;160:985-991.
7. Burrow GN, Fisher DA, Reed Larsen P. Maternal and fetal thyroid function. N Engl J Med 1994;331:1072-1078.
8. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, Cunningham FG. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005;105:239-245. (Pubitemid 40229436)
9. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeold A, Bianco AC. Cellular and molecular basis of deiodinaseregulated thyroid hormone signaling. Endocr Rev 2008;29:898-938.
10. Glinoer D. Maternal thyroid function in pregnancy. J Endocrinol Invest 1993; 16:374-378. (Pubitemid 23197250)
11. Glinoer D. The regulation of thyroid function in pregnancy: Pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997; 18:404-433. (Pubitemid 27246883)
12. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Heros RJ, Waisbren SE et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341:2015-2017.
13. Haddow JE, McClain MR, Palomaki GE, Kloza EM, Williams J. Screening for thyroid disorders during pregnancy: Results of a survey in Maine. Am J Obstet Gynecol 2006;194:471-474. (Pubitemid 43183703)
14. Haddow JE, McClain MR, Lambert-Messerlian G, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P et al. First- and Second-Trimenster Evaluation of Risk for Fetal Aneuplidy Research Consortium. Variability in thyroid-stimulating hormone suppression by human chorionic gonadotropin during early pregnancy. J Clin Endocrinol Metab 2008;93:3341-3347.
15. Hershman JM. The role of human chorionic gonadotropin as a thyroid stimulator in normal pregnancy. J Clin Endocrinol Metab 2008; 93:3305-3306.
16. Huang SA, Dorfman DM, Genest DR, Salvatore D, Reed Larsen P. Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J Clin Endocrinol Metab 2003;88:1384-1388. (Pubitemid 36337804)
17. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 2006;21:2216-2222. (Pubitemid 44530592)
18. Lambert-Messerlin G, McClain M, Haddow JE, Polomaki GE, Canick JA, Clary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P et al. FaSTER Research Consortium. First- and second trimester thyroid hormone reference data in pregnant women: A FaSTER (Firstand Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium Study. Am J Obestet Gynecol 2008;199:62.e1-62. e6.
19. Laoag-Fernandez JB, Matsuo H, Murakoshi H, Hamada AL, Tsang BK, Maruo T. 3,5,3'-Triiodothyronine down-regulates Fas and Fas ligand expression and suppresses Caspase-3 and Poly (Adenosine 5'-diphoshateribose) polymerase cleavage and Apoptosis in early placental extravillous trophoblasts in vitro. J Clin Endocrinol Metab 2004;89:4069-4077. (Pubitemid 39071515)
20. Mandel SJ, Larsen PR, Seely EW, Brent GA. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med 1990;323:91-96. (Pubitemid 20221645)
21. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: Effects on obstetrical complications. J Clin Endocrinol Metab 2006;91:2587-2591. (Pubitemid 44024622)
22. Negro R, Formoso G, Coppola L, Presicce G, Mangieri T, Pezzarossa A, Dazzi D. Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: The role of autoimmunity and thyroid function. J Endocrinol Invest 2007;30:3-8. (Pubitemid 46470376)
23. Nishii H, Ashitaka Y, Maruo M, Mochizuki M. Studies on the nuclear 3,5,3'-Triiodo-L-thyronine binding sites in cytotrophoblast. Endocrinol Jpn 1989;36:891-898. (Pubitemid 20174895)
24. Oki N, Matsuo H, Nakago S, Murakoshi H, Laoag-Fernandez JB, Maruo T. Effects of 3,5,3'- triiodothyronine on the invasive potential and the expression of integrins and matrix metalloproteinases in cultured early placental extravillous trophoblasts. J Clin Endocrinol Metab 2004; 89:5213-5221. (Pubitemid 39391471)
25. Peck TM, Arias F. Hematologic changes associated with pregnancy. Clin Obstet Gynecol 1979;22:785-798. (Pubitemid 10173551)
26. Poppe K, Velkeniers B, Glinoer D. Thyroid disease and female reproduction. Clin Endocrinol (Oxf) 2007;66:309-321. (Pubitemid 46239305)
27. Rao VR, Lakshmi A, Sadhnani MD. Prevalence of hypothyroidism in recurrent pregnancy loss in first trimester. Indian J Med Sci. 2008; 62:357-61.
28. Rashid M, Rashid MH. Obstetric management of thyroid disease. Obstet Gynecol Surv 2007;62:680-688. (Pubitemid 47493930)
29. Soldin OP, Soldin D, Sastoque M. Gestation-specific thyroxine and thyroid stimulating hormone levels in the United States and worldwide. Ther Drug Monit 2007;29:553-559. (Pubitemid 47494051)
30. Stagnaro-Green A. Maternal Thyroid disease and preterm delivery. J Clin Endocrinol Metab 2009;94:21-25.
31. Stagnaro-Green A, Glinoer D. Thyroid autoimmunity and risk of miscarriage. Best Pract Res Clin Endocrinol Metab 2004;18:167-181.
32. Vaquero E, Lazzarin N, De Carolis C, Valensise H, Moretti C, Romanini C. Mild thyroid abnormalities and recurrent spontaneous abortion: Diagnostic and therapeutical approach. Am J Reprod Immunol 2000; 43:204-208. (Pubitemid 30229675)
33. Wier FA, Farley CL. Clinical controversies in screening women for thyroid disorders during pregnancy. J Midwifery Womens Health 2006; 51:152-158.